Spectrum Sinks After Poziotinib Fail In NSCLC

Shares Slide 60%

 
• By Kevin Grogan
  
SC1805_Falling OffHorse_585258497_1200.jpg
Spectrum takes a tumble after trial disappointment • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D